BIODESIX INC — Director's Dealing 2022

Jan 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-01-13

Reporting Person: Cowie Robin Harper (CFO, Sec'y & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-13	Common Stock	M	2520	$0.42	Acquired	44495	Direct
2022-01-13	Common Stock	M	3159	$0.42	Acquired	47654	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-13	Stock Options (Right to buy)	$0.42	M	2520	Disposed	2027-05-15	Common Stock (2520)	Direct
2022-01-13	Stock Options (Right to buy)	$0.42	M	3159	Disposed	2028-04-03	Common Stock (3159)	Direct

Footnotes

F1: This option vested in 60 successive, equal monthly installments measured from January 1, 2017.

F2: This option vests in 60 successive, equal monthly installments measured from January 1, 2018.